Description
Overview
The GSP Neonatal Total Galactose Kit is a reliable and accurate diagnostic kit designed to support newborn screening programs by enabling the quantitative determination of total galactose concentrations in dried blood spot (DBS) specimens. Total galactose is defined as the combined measurement of free galactose and galactose-1-phosphate, two key markers that are elevated in infants affected by galactosemia.
The GSP Neonatal Total Galactose Kit is specifically optimized for use with dried blood spot samples collected on filter paper, the standard medium for newborn screening laboratories worldwide. This method ensures minimally invasive sample collection, simplified transport and storage, and compatibility with high-throughput screening workflows. The kit is designed to deliver quantitative, reproducible, and clinically relevant results, supporting both laboratory efficiency and diagnostic confidence.
With its clear methodology, consistent performance, and robust design, the Neonatal Total Galactose Kit serves as a critical component of comprehensive newborn screening panels. It not only helps identify infants at risk of galactosemia but also contributes to broader efforts to detect and manage rare metabolic conditions during the earliest stages of life.
By incorporating this assay into newborn screening programs, healthcare providers and public health systems can ensure that affected infants receive prompt dietary management reducing the risk of complications and enhancing long-term quality of life.
The Neonatal Total Galactose Kit reflects a commitment to advancing newborn health through early, accurate, and accessible screening solutions, empowering clinicians and laboratories to safeguard the well-being of the youngest patients.
